Navigation Links
Intermittent Catheter Market Currently Valued at $230 Million and Set to Double by 2014
Date:10/26/2010

TORONTO, Oct. 26 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to 200 catheters per month, instead of the previous 4 that it covered. Over the past two years, market growth has been fueled by patients who have switched to a single-use regimen. There is, however, still tremendous growth potential in this market because the majority of patients who regularly use intermittent catheters are still generally comfortable reusing catheters because this has been a standard practice for many years. These patients typically use only four or five catheters per month.  

Supported by its strong sales force, Coloplast had over 50% of the market in 2009, with C.R. Bard, Astra Tech, Rusch, and Hollister also accounting for a notable share in this segment that year. A substantial sales force is necessary to develop appropriate relationships with health care providers -- in order to ensure that prescriptions are being written specifically for a manufacturer's device -- and with distributors -- in order to ensure that they promote specific devices to end users. The dominant presence of larger competitors in this market and their existing relationships with health care providers and distributors may therefore prevent smaller competitors from entering or being more successful in this segment.

"In order to be successful, manufacturers will need to develop these relationships with health care providers and medical product distributors," says Aaron McCracken, Principal Analyst at MRG. "Companies will also need to brand their products directly to patients to ensure that they ask for a specific brand when ordering catheters from a distributor."

MRG's US Markets for Urological Devices 2010 report provides critical insight into trends that will fuel and limit market growth for urological devices in the US. The report includes a breakdown of unit volumes, average selling prices, and market values for urinary incontinence devices (for example, urinary catheters and vaginal slings), urological endoscopes, and devices used to treat conditions such as kidney stones, prostate cancer, prostatic hyperplasia, and erectile dysfunction.  

WebinarOn Wednesday November 17, at 11:00 am eastern time, MRG is offering a webinar for purchasers of the US Markets for Urological Devices 2010 report.  For more information, please contact Amy Krohn at 416-364-7776 ext. 101 or akrohn@mrg.net.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris ComfortDecision Resources, Inc. 781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
2. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
3. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
4. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
5. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
6. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
7. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
8. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
9. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... the Peace Agreements being discussed by President Donald Trump and the rest of the ... to speed up peace talks in the continuous battle between Israel and Palestine. The ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “When the ... Lead Home” is the creation of published author Laura Weigel Douglas, an avid reader ... cat in a house that sometimes feels like Green Hills Adventure Camp. She couldn’t ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Cactus Jack: Against All Odds”: ... many others. “Cactus Jack: Against All Odds” is the creation of published author, ... Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter and Jane ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... Dr. Alan ... surgery in New York City. He is known for his distinguished expertise and ... vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease and aortic ...
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
Breaking Medicine News(10 mins):